Gregory Norden
Director/Board Member at ROYALTY PHARMA PLC
Net worth: 14 M $ as of 2024-03-30
Profile
Gregory Norden is currently serving as an Independent Director at Zoetis, Inc., NanoString Technologies, Inc., RP Management LLC, G9 Capital Group LLC, Praxis Precision Medicines, Inc., Anthos Therapeutics, Inc., and Royalty Pharma Plc.
He previously held positions as a Director at AMAG Pharma USA, Inc., Human Genome Sciences, Inc., Univision Communications, Inc., Welch Allyn, Inc., Greatwide Logistics Services LLC, Univision Holdings, Inc., Entasis Therapeutics, Inc., and Entasis Therapeutics Holdings, Inc. He also served as the Chief Financial Officer & Senior Vice President at Wyeth LLC and as the Vice President-Finance at Ayerst Laboratories, Inc. Mr. Norden received his undergraduate degree from the State University of New York College at Plattsburgh and his graduate degree from Long Island University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RPI US Partners 2019 LP
0.07% | 2020-06-15 | 155,940 ( 0.07% ) | 5 M $ | 2024-03-30 |
| 2023-04-10 | 144,660 ( 0.06% ) | 4 M $ | 2024-03-30 | |
ZOETIS, INC. CLASS A
0.00% | 2024-02-20 | 15,111 ( 0.00% ) | 3 M $ | 2024-03-30 |
| 2023-06-22 | 64,445 ( 0.01% ) | 2 M $ | 2024-03-30 | |
| 2023-09-29 | 188 ( 0.00% ) | 11 472 $ | 2024-03-30 | |
| 2023-06-22 | 47,419 ( 0.10% ) | 3 794 $ | 2024-03-30 |
Gregory Norden active positions
| Companies | Position | Start |
|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Director/Board Member | 2012-07-17 |
| ZOETIS INC. | Director/Board Member | 2012-12-31 |
| ROYALTY PHARMA PLC | Director/Board Member | 2020-02-10 |
| PRAXIS PRECISION MEDICINES, INC. | Director/Board Member | 2019-02-28 |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Director/Board Member | 2018-12-31 |
Former positions of Gregory Norden
| Companies | Position | End |
|---|---|---|
Welch Allyn, Inc.
 Welch Allyn, Inc. Medical SpecialtiesHealth Technology Welch Allyn, Inc. develops and manufactures medical diagnostic and therapeutic devices. Its products include physical exam, patient monitoring, blood pressure measurement, thermometry, cardiopulmonary, medical lighting, animal health, and population health management technologies. It also offers batteries, lamps, cables and sensors, power supplies, cords and chargers, connectors and tubing, and probe covers and thermometry. The company was founded by Francis Welch and William Noah Allyn in 1915 and is headquartered in Skaneateles Falls, NY. | Director/Board Member | 2014-12-31 |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Director/Board Member | 2013-12-31 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | 2011-12-31 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Director of Finance/CFO | 2009-12-31 |
Training of Gregory Norden
| Long Island University | Graduate Degree |
| State University of New York College at Plattsburgh | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| ZOETIS INC. | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Univision Communications, Inc.
 Univision Communications, Inc. BroadcastingConsumer Services Univision Communications, Inc. provides television and radio network services. It operates a Spanish-language broadcast television network. The firm produces and delivers content across various media platforms to inform, entertain, and empower Hispanic America. The company was founded in 1961 and is headquartered in New York, NY. | Consumer Services |
Welch Allyn, Inc.
Welch Allyn, Inc. Medical SpecialtiesHealth Technology Welch Allyn, Inc. develops and manufactures medical diagnostic and therapeutic devices. Its products include physical exam, patient monitoring, blood pressure measurement, thermometry, cardiopulmonary, medical lighting, animal health, and population health management technologies. It also offers batteries, lamps, cables and sensors, power supplies, cords and chargers, connectors and tubing, and probe covers and thermometry. The company was founded by Francis Welch and William Noah Allyn in 1915 and is headquartered in Skaneateles Falls, NY. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Greatwide Logistics Services LLC
 Greatwide Logistics Services LLC Air Freight/CouriersTransportation Greatwide Logistics Services, Inc. provides transportation, truckload management, and logistics services. It offers labour, warehousing and transportation management solutions, reverse logistics, inventory visibility, key performance indicator and metrics reporting, food grade facilities, and cross-docking, import deconsolidation and merge in-transit operations. The company was founded in 1967 and is headquartered in Dallas, TX. | Transportation |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Gregory Norden
